Ultragenyx Highlights Presentation Of Multi-Year Durability Data From Ongoing Phase 1/2 Gene Therapy Studies And Data On HeLa 3.0 Manufacturing Platform At American Society of Gene & Cell Therapy 2021 Annual Meeting